Skip to main content

Siren, L.L.C.

Position in AGMB — Agomab Therapeutics NV

CIK 2005245 New York, NY

Position in AGMB

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$4,314,012
New position
Shares Held
411,250
first reported quarter
Ownership
0.835%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Siren, L.L.C. holds $3,359,319,188 across 68 Biotechnology names. AGMB ranks #61 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AGMB

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 $4,314,012 411,250